Pharmacodynamic Effects of Litifilimab in Lupus in the LILAC Phase II Study: Rapid and Sustained Reductions in Type I Interferon‐Associated Gene Expression and Cytokines

Journal:

Arthritis & Rheumatology

Published:

2025-06-10

DOI:

10.1002/art.43271

Affiliations:

6

Authors:

9

Go to article

Institutions	Authors	Share
Biogen, United States of America (USA)	6.000000	0.67
Biogen Switzerland AG, Switzerland	1.000000	0.11
Northwell Health, United States of America (USA)	1.000000	0.11
University of Pennsylvania (Penn), United States of America (USA)	0.500000	0.06
Corporal Michael J. Crescenz VA Medical Center (CMCVAMC), United States of America (USA)	0.500000	0.06

Interested in Neurosciences?